The development of hirudin as an antithrombotic drug

Haycraft, 1894, Über die Einwirkung eines Sekretes des officinellen Blutegels auf die Gerinnbarkeit des Bluts, Naunyn Schmiedeberg's Arch Exp Pathol Pharmak, 18, 209, 10.1007/BF01833843

Franz, 1903, Über den die Blutgerinnung aufhebenden Bestandteil des medizinischen Blutegels, Naunyn Schmiedeberg's Arch Exp Pathol Pharmak, 49, 342, 10.1007/BF01825055

Jacobi, 1904, Über Hirudin, Deutsch Med Wochenschr, 30, 1786

Markwardt, 1955, Untersuchungen über Hirudin, Naturwissenschaften, 42, 537, 10.1007/BF00630151

Markwardt, 1956, Die antagonistische Wirkung des Hirudins gegen Thrombin in vivo, Naturwissenschaften, 43, 111, 10.1007/BF00600885

Markwardt, 1956, Untersuchungen über den Mechanismus der blutgerinnungshemmenden Wirkung des Hirudins, Naunyn Schmiedeberg's Arch Exp Pathol Pharmacol, 229, 389, 10.1007/BF00245864

Markwardt, 1957, Die Isolierung und chemische Charakterisierung des Hirudins, Hoppe Seylers Z Physiol Chem, 308, 147, 10.1515/bchm2.1957.308.1.147

Markwardt, 1958, Versuche zur pharmakologischen Charakterisierung des Hirudins, Naunyn Schmiedeberg's Arch Exp Pathol Pharmacol, 234, 516

Markwardt, 1958, Die Reaktion zwischen Hirudin und Thrombin, Hoppe Seylers Z Physiol Chem, 312, 85, 10.1515/bchm2.1958.312.1.85

Markwardt, 1959, Über den Einflußzlig; des Hirudins auf die Thrombin-bildung, Naunyn Schmiedeberg's Arch Exp Pathol Pharmacol, 236, 286

Markwardt, 1958, Hirudin, der blutgerinnungshemmende Wirkstoff des medizinischen Blutegels, Blut, 4, 161, 10.1007/BF01631742

Markwardt, 1957, Die Bestimmung des Thrombins durch Titration mit Hirudin, Arch Pharmazie, 290, 280, 10.1002/ardp.19572900607

Markwardt, 1958, Die quantitative Bestimmung des Prothrombins durch Titration mit Hirudin, Naunyn Schmiedeberg's Arch Exp Pathol Pharmacol, 232, 487, 10.1007/BF00245868

Markwardt, 1959, Der Hirudintoleranztest, Klin Wochenschr, 37, 1142, 10.1007/BF01484579

Schmutzler, 1962, Der Hirudintest, eine Mikromethode zur Kontrolle des Prothrom Prothrombinspiegels bei der Antikoagulantientherapie, Klin Wochenschr, 40, 796, 10.1007/BF01481255

Markwardt, 1961, Die Anwendung der Prothrombinbe-stimmung mit Hirudin zur überwachung der Behandlung mit Dicumarolderivaten, Blut, 7, 37, 10.1007/BF01636464

Jutisz, 1963, Purification de l'hirudine, Bull Soc Chim Biol, 45, 55

Markwardt, 1967, Die Isolierung des Hirudins aus medizinischen Blutegeln, Pharmazie, 22, 239

Markwardt, 1967, Reindarstellung und Analyse des ThrombinInhibitors Hirudin, Hoppe Seylers Z Physiol Chem, 348, 1381, 10.1515/bchm2.1967.348.1.1381

Bagdy, 1973, Large scale preparation of hirudin, Thromb Res, 2, 229, 10.1016/0049-3848(73)90086-8

Walsmann, 1985, On the isolation of the thrombin inhibitor hirudin, Thromb Res, 40, 563, 10.1016/0049-3848(85)90293-2

Markwardt, 1970, Hirudin as an inhibitor of thrombin, Vol. XIX, 924

Petersen, 1976, Primary structure of hirudin, a thrombin-specific inhibitor, 145

Markwardt, 1982, Pharmacological studies on the antithrombotic action of hirudin in experimental animals, Thromb Haemost, 47, 226, 10.1055/s-0038-1657173

Markwardt, 1983, Influence of thrombin inhibitors on the thrombin-induced activation of human blood platelets, Haemostasis, 13, 227

Ishikawa, 1980, The effect of hirudin on endotoxin induced disseminated intravascular coagulation (DIC), Thromb Res, 19, 351, 10.1016/0049-3848(80)90263-7

Markwardt, 1984, Pharmacokinetics and anticoagulant effect of hirudin in man, Thromb Haemost, 52, 160, 10.1055/s-0038-1661163

Nowak, 1980, Influence of hirudin on endotoxin-induced disseminated intravascular coagulation (DIC) in weaned pigs, Exp Pathol, 18, 438

Markwardt, 1983, Comparative studies on thrombin inhibitors in experimental microthrombosis, Thromb. Haemost, 49, 235, 10.1055/s-0038-1657370

Bichler, 1988, Pharmacokinetics and pharmacodynamics of hirudin in man after single subcutaneous and intravenous bolus administration, Arzneimittelforschung, 38, 704

Dodt, 1984, The complete amino acid sequence of hirudin, a thrombin specific inhibitor, FEBS Lett, 165, 180, 10.1016/0014-5793(84)80165-9

Dodt, 1985, The complete covalent structure of hirudin, 366, 379

Dodt, 1986, Isolation and characterization of hirudin isoinhibitors and sequence analysis of hirudin PA, Biol Chem Hoppe Seyler, 367, 803, 10.1515/bchm3.1986.367.2.803

Tripier, 1988, Hirudin: A family of iso-proteins isolation and sequence determination of new hirudins, Folia Haematol, 115, 30

Scharf, 1989, Primary structures of new iso-hirudins', FEBS Lett, 225, 105, 10.1016/0014-5793(89)81070-1

Stone, 1986, Kinetics of the inhibition of thrombin by hirudin, Biochemistry, 25, 4622, 10.1021/bi00364a025

Konno, 1988, Analysis of the secondary structure of hirudin and the mechanism of its interaction with thrombin, Arch Biochem Biophys, 267, 158, 10.1016/0003-9861(88)90019-7

Rydel, 1991, Refined structure of the hirudin-thrombin complex, J Mol biol, 20, 583, 10.1016/0022-2836(91)80074-5

Rydel, 1990, The structure of a complex of recombinant hirudin and human-thrombin, Science, 249, 277, 10.1126/science.2374926

Harvey, 1986, Cloning and expression of cDNA coding for the anticoagulant hirudin from the blood sucking leech, 83, 1084

Bergmann, 1986, Chemical synthesis and expression of a gene coding for hirudin, the thrombin-specific inhibitor from the leech Hirudo medicinalis, Biol Chem Hoppe Seyler, 367, 731, 10.1515/bchm3.1986.367.2.731

Grossenbacher, 1987, Isolation and characterization of recombinant desulfatohirudin from yeast, a highly selective thrombin inhibitor, Thromb Res, 7, 34, 10.1016/0049-3848(87)90027-2

Markwardt, 1988, Pharmacological survey of recombinant hirudin, Pharmazie, 43, 202

Markwardt, 1988, Clinico-pharmacological studies with recombinant hirudin, Thromb Res, 52, 393, 10.1016/0049-3848(88)90023-0

Markwardt, 1987, Studies on the pharmacokinetics of hirudin, Biomed Biochim Acta, 46, 237

Markwardt, 1989, Studies on antithrombotic effects of recombinant hirudin, Thromb Res, 54, 377, 10.1016/0049-3848(89)90208-9

Vogel, 1987, Preliminary clinical reports on the antithrombotic action of hirudin, Thromb Res (Suppl.), 7, 42, 10.1016/0049-3848(87)90035-1

Parent, 1993, Treatment of severe venous thrombo-embolism with intravenous hirudin (HBW 023): An open pilot study, Thromb Haemost, 70, 386, 10.1055/s-0038-1649590

Meyer, 1990, The pharmacology of recombinant hirudin, a new anticoagulant, South Afr Med J, 78, 268

Markwardt, 1991, Clinical pharmacology of recombinant hirudin, Haemostasis, 21, 133

Glusa, 1992, Studies in human pharmacology of recombinant hirudin, Thromb Res, 65, 118, 10.1016/0049-3848(92)90549-P

NURMOHAMED, M.T., KNIPSCHEER, H.C., BULLER, H.R. and CATE, J.W. An open study to investigate the biological efficacy of repeated subcutaneous applications of r-hirudin (CGP 39393) in healthy volunteers. Thromb Haemost 65, 650, 191.

Markwardt, 1989, Hirudin als potentielles Antikoagulans zur Prävention der Rethrombosierung nach intrakoronarer Lyse und Angioplastie, Hämostaseologie, 9, 204, 10.1055/s-0038-1655271

Markwardt, 1990, Prospective clinical use of hirudin as an anticoagulant, Biomed. Prog., 3, 19

Bagdy, 1976, Hirudin, Methods Enzymol, 45, 669, 10.1016/S0076-6879(76)45057-7

Markwardt, 1985, Pharmacology of hirudin: One hundred years after the first report of the anticoagulant agent, Biomed Biochim Acta, 44, 1007

Markwardt, 1988, Biochemistry and pharmacology of hirudin, 255

Markwardt, 1988, The comeback of hirudin-An old-established anticoagulant agent, Folia Haematol (Lpz), 115, 10

Markwardt, 1989, Development of hirudin as an antithrombotic agent, Semin Thromb Hemost, 15, 269, 10.1055/s-2007-1002719

Markwardt, 1991, Past, present and future of hirudin, Haemostasis, 21, 11

Hoet, 1990, Hirudo medicinalis and hirudin, Vol. 3, 223

Markwardt, 1991, Hirudin and derivatives as anticoagulant agents, Thrombos Haemostas, 66, 141, 10.1055/s-0038-1646383

Markwardt, 1991, The development of hirudin as an anticoagulant agent, Curr Cardiovasc Patents, 1, 981

Markwardt, 1992, Hirudin: The promising antithrombotic, Cardiovasc Drug Rev, 10, 211, 10.1111/j.1527-3466.1992.tb00247.x

Müller-Berghaus, 1992, Hirudin update, 133

Märki, 1991, Recombinant hirudin: Genetic engineering and structure analysis, Semin Thromb Hemost, 17, 88, 10.1055/s-2007-1002594

Fareed, 1989, Development perspectives for recombinant hirudin as an anti-thrombotic agent, Biol Clin Hematol, 11, 143

Walenga, 1990, Recombinant hirudin as antithrombotic agent, Drugs Future, 15, 267

Stürzebecher, 1991, Structure-activity relationships of recombinant hirudins, Semin Thromb Hemost, 17, 94, 10.1055/s-2007-1002595

Johnson, 1989, Biochemistry and genetic engineering of hirudin, Sem Thromb Hemost, 15, 302, 10.1055/s-2007-1002723

Lindhout, 1990, The anticoagulant mechanism of action of recombinant hirudin (39393) in plasma, Thromb Haemost, 64, 464, 10.1055/s-0038-1647337

Ofuso, 1992, Inhibition of the amplification reactions of blood coagulation by site-specific inhibitors of alpha-thrombin, Biochem J, 283, 893, 10.1042/bj2830893

Hauptmann, 1987, Effect of heparin, hirudin and a synthetic thrombin inhibitor on antithrombin III in thrombin-induced disseminated intravascular coagulation in rats, Hemostasis, 17, 321

Walsmann, 1981, Biochemische und pharmakologische Aspekte des Thrombininhibitors Hirudin, Pharmazie, 36, 653

Glusa, 1990, Platelet functions in recombinant hirudin-anticoagulated blood, Hemostasis, 20, 112

Glusa, 1991, Hirudin and platelets, Semin Thromb Hemost, 17, 122, 10.1055/s-2007-1002599

Glusa, 1980, Adrenaline-induced reactions of human platelets in hirudin plasma, Hemostasis, 9, 188

Markwardt, 1990, Antithrombin effects of native and recombinant hirudins, Biomed Biochim Acta, 49, 399

Glusa, 1988, Studies on thrombin-induced endothelium-dependent vascular effects, Biomed Biochim Acta, 47, 623

Markwardt, 1986, Pharmacological approaches to thrombin regulation, Ann NY Acad Sci, 485, 204, 10.1111/j.1749-6632.1986.tb34582.x

Obberghen-Schilling, 1982, Hirudin, a probe to analyze the growth promoting activity of thrombin in fibroblasts; Reevaluation of the temporal action of competence factors, Biochem Biophys Res Commun, 105, 79, 10.1016/0006-291X(82)92060-5

Klöcking, 1988, Influence of hirudin on the thrombin-induced release of tissue plasminogen activator from isolated perfused pig ear, Folia Haematol, 115, 110

Markwardt, 1990, Pharmacological modification of mechanical and electrical responses of frog heart to thrombin, Naunyn Schmiedeberg's Arch Pharmacol, 341, 341, 10.1007/BF00180660

Walsmann, 1988, Über den Einsatz des spezifischen Thrombin-Inhibitors Hirudin für diagnostische und biochemische Untersuchungen, Pharmazie, 43, 737

Markwardt, 1980, Hirudin-Biochemisch-pharmakologische Wirkung und Anwendung zur gerinnungsphysiologischen Diagnostik, 105

Stocker, 1991, Laboratory use of hirudin, Semin Thromb Hemost, 17, 113, 10.1055/s-2007-1002598

Zoldhelyi, 1993, Hirudin as a molecular probe for thrombin in vitro and during systemic coagulation in the pig, 90, 1819

Griessbach, 1985, Assay of hirudin in plasma using a chromogenic thrombin substrate, Thromb Res, 37, 347, 10.1016/0049-3848(85)90023-4

Markwardt, 1990, The hirudin standard, Thromb Res, 59, 395, 10.1016/0049-3848(90)90143-Z

Stürzebecher, 1991, Methods for determination of hirudin, Semin Thromb Hemost, 17, 99, 10.1055/s-2007-1002596

Stürzebecher, 1982, Are synthetic inhibitors able to improve factor Xa assays using peptide substrates?, Thromb Res, 26, 221, 10.1016/0049-3848(82)90143-8

Markwardt, 1992, Haemostyptic effects of batroxobin with regard to hirudin treatment, Thromb Res, 68, 475, 10.1016/0049-3848(92)90060-N

Walenga, 1991, Comparative studies on various assays for the laboratory evaluation of r-hirudin, Semin Thromb Hemost, 17, 103, 10.1055/s-2007-1002597

Klöcking, 1990, Studies in toxicity of recombinant hirudin, Blut, 60, 129

Klöcking, 1991, Toxicology of hirudin, Sem Thromb Hemost, 17, 126, 10.1055/s-2007-1002600

Bichler, 1991, Studies for revealing a possible sensitization to hirudin after repeated intravenous injection in baboons, Thromb Res, 61, 39, 10.1016/0049-3848(91)90167-U

Richter, 1988, Pharmacokinetics of 125I-hirudin in rats and dogs, Folia Haematol, 115, 64

Markwardt, 1988, Pharmacokinetics of recombinant hirudin in primates (abstract), Fed Proc, 1, 484

Henschen, 1988, Evidence for the identity of hirudin isolated after kidney passage with the starting material, Folia Haematol, 115, 59

Nowak, 1988, Pharmacokinetic studies with recombinant hirudin in dogs, Folia Haematol, 115, 70

Nowak, 1991, Pharmacokinetics of hirudin, Semin Thromb Hemost, 17, 145, 10.1055/s-2007-1002603

Iyer, 1993, Studies on the pharmacokinetics and pharmacodynamics of recombinant hirudin (rHV2-Lys 47) after intravenous and subcutaneous administration in dogs, Thromb Res, 69, 259, 10.1016/0049-3848(93)90003-7

Iyer, 1993, Alteration of pharmacokinetics and pharmaco-dynamics of recombinant hirudin (rHV2-Lys 47) after repeated intravenous administration in dogs, Thromb Res, 69, 59, 10.1016/0049-3848(93)90003-7

Richter, 1989, Plasma level of dextran-r-hirudin, Pharmazie, 44, 73

Markwardt, 1990, Preparation of dextran-bound recombinant hirudin and its pharmacokinetic behaviour, Biomed Biochim Acta, 49, 1103

Ito, 1991, Thrombin inhibition by covalently bound hirudin, Blood Coag Fibrinol, 2, 77, 10.1097/00001721-199102000-00012

Rübsamen, 1991, Reocclusion after thrombolysis: A problem solved by hirudin, Blood Coag Fibrinol, 2, 97, 10.1097/00001721-199102000-00015

Kaiser, 1986, Antithrombotic and haemorrhagic effects of synthetic and naturally occurring thrombin inhibitors, Thromb Res, 43, 613, 10.1016/0049-3848(86)90098-8

Agnelli, 1990, The comparative effects of recombinant hirudin (CGP 39393) and standard heparin on thrombus growth in rabbits, Thromb Haemost, 63, 204, 10.1055/s-0038-1645195

Krupinski, 1989, Antithrombotic effects of three thrombin inhibitors in a rat model of laser-induced thrombosis, Haemostasis, 19, 74

Doutremepuich, 1989, Antithrombotic activity of recombinant hirudin in the rat: A comparative study with heparin, Thromb Res, 54, 435, 10.1016/0049-3848(89)90213-2

Kaiser, 1991, Anticoagulant and antithrombotic actions of recombinant hirudin, Semin Thromb Hemost, 17, 130, 10.1055/s-2007-1002601

Talbot, 1989, Recombinant desulphatohirudin (CGP 39393) anticoagulant and antithrombotic properties in vivo, Thromb Haemost, 61, 77, 10.1055/s-0038-1646530

Just, 1991, Antithrombotic effects of recombinant hirudin in different animal models, Haemostasis, 21, 80

Gray, 1991, Experimental studies on a recombinant hirudin, Thromb Haemost, 65, 355, 10.1055/s-0038-1648151

Klöcking, 1989, Influence of recombinant hirudin on the thrombogenicity of prothrombin complex concentrates, Pharmazie, 44, 341

Raake, 1991, Antithrombotic action of recombinant hirudin in a venous thrombosis model, Haemostasis, 21, 127

Bara, 1992, A comparative study of recombinant hirudin and standard heparin in the Wessler model, Thromb Res, 68, 167, 10.1016/0049-3848(92)90032-6

Imura, 1992, Comparative antithrombotic effects of heparin, recombinant hirudin and argatroban in a hamster femoral vein platelet-rich mural thrombosis model, J Pharmacol Exp Ther, 261, 895

Bucha, 1988, Prevention of experimental coronary thrombosis by hirudin, Folia Haematol, 115, 52

Markwardt, 1987, Prevention of coronary thrombosis by hirudin, 449

Heras, 1989, Effects of thrombin inhibition on the development of acute platelet-thrombus deposition during angioplasty in pigs, 79, 657

Kaiser, 1990, Antithrombotic effects of recombinant hirudin in experimental angioplasty and intra vascular thrombolysis, Thromb Haemost, 63, 44, 10.1055/s-0038-1645684

Rübsamen, 1991, Effect of recombinant hirudin (LU 52369) on reocclusion rates after thrombolysis in rabbits, Haemostasis, 21, 93

Zawilska, 1993, The effect of a long-acting recombinant hirudin (PEG-hirudin) on experimental disseminated intravascular coagulation (DIC) in rabbits, Thromb Res, 69, 315, 10.1016/0049-3848(93)90029-N

Sarembock, 1991, Effectiveness of recombinant desulphatohirudin in reducing restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits, Circulation, 84, 432, 10.1161/01.CIR.84.1.232

May, 1992, The pharmacological modulation of thrombin-induced cerebral thromboembolism in the rabbit, Br J Pharmacol, 106, 133, 10.1111/j.1476-5381.1992.tb14305.x

Rigel, 1993, Comparison of hirudin and heparin as adjuncts to streptokinase thrombolysis in a canine model of coronary thrombosis, Circ Res, 72, 1091, 10.1161/01.RES.72.5.1091

Hoffmann, 1990, Effect of recombinant hirudin, a specific inhibitor of thrombin, on endotoxin-induced intravascular coagulation and acute lung injury in pigs, Am Rev Respir Dis, 142, 782, 10.1164/ajrccm/142.4.782

Hauptmann, 1988, Influence of hirudin on the consumption of antithrombin III in experimental DIC, Folia Haematol, 115, 83

Freund, 1990, Inhibition by recombinant hirudins of experimental venous thrombosis and disseminated intravascular coagulation induced by tissue-factor in rats, Thromb Haemost, 63, 187, 10.1055/s-0038-1645193

Nowak, 1991, Hirudin in disseminated intravascular coagulation, Haemostasis, 2, 142

Markwardt, 1992, Experience with hirudin and other thrombin inhibitors in disseminated intravascular coagulation, 115

Bucha, 1990, Hirudin in haemodialysis, Thromb Res, 60, 445, 10.1016/0049-3848(90)90229-6

Markwardt, 1991, Hirudin as anticoagulant in experimental haemodialysis, Haemostasis, 21, 149

Walenga, 1991, The potential use of r-hirudin as an anticoagulant in cardiopulmonary bypass model, Blood Coagul Fibrinol, 2, 105, 10.1097/00001721-199102000-00017

Markwardt, 1988, Pharmacology of selective thrombin inhibitors, Nouv Rev Fr Hematol, 30, 161

Fareed, 1991, Neutralization of recombinant hirudin, 17, 137

Brüggener, 1989, Neutralization of hirudin anticoagulant action by DIP-thrombin, Pharmazie, 44, 648

Walsmann, 1981, Untersuchungen zur Affinitätschromatographie von Hirudin an trägerfixiertem, Thrombin. Pharmazie, 36, 860

Fareed, 1989, Do we need to neutralize hirudin's anticoagulant effects to minimize bleeding?, Fed Proc, 3, A 328

Henschen, 1987, Identification by HPLC analysis of the unaltered forms of hirudin and desulfated hirudin after kidney passage (abstract), Thromb Res, 7, 37, 10.1016/0049-3848(87)90030-2

Zoldhelyi, 1993, Recombinant hirudin in patients with chronic, stable coronary artery disease, 88, 2015

Walenga, 1989, Development of recombinant hirudin as a therapeutic anticoagulant and antithrombotic agent: Some objective considerations, Semin Thromb Hemost, 15, 316, 10.1055/s-2007-1002724

Nowak, 1992, Pharmacology of r-hirudin in renal impairment, Thromb Res, 66, 707, 10.1016/0049-3848(92)90046-D

Vogel, 1988, Clinical use of hirudin, Folia haematol., 115, 113

Breddin, 1903, Clinical experience with hirudin in disseminated intravascular coagulation, Thrombos Haemostas, 69, 1299

van den Bos, 1993, Safety and efficacy of recombinant hirudin (CGP 39 393) versus heparin in patients with stable angina undergoing coronary angioplasty, Circulation, 88, 2058, 10.1161/01.CIR.88.5.2058

Neuhaus, 1993, r-Hirudin and front-loaded alteplase in acute myocardial infarction: Results of the HIT (Hirudin for Improvement of Thrombolysis) study, Eur Heart J, 14, 106

Cannon, 1993, Hirudin reduces reocclusion compared to heparin following thrombolysis in acute myocardial infarction: results of the TIMI 5 trial, J Am Coll Cardiol, 21, 136A

Hauptmann, 1992, Pharmacologic aspects of the development of selective synthetic thrombin inhibitors as anticoagulants, Semin Thromb Hemost, 18, 200, 10.1055/s-2007-1002426

Maraganore, 1990, Design and characterization of hirulogs: A novel class of bivalent peptide inhibitors of thrombin, Biochemistry, 29, 7095, 10.1021/bi00482a021

Markwardt, 1994, Coagulation inhibitors of blood-sucking animals-A new line of developing antithrombotic drugs, Pharmazie, 49, 202